CienciaySaludNatural.com
El público está en alerta por miocarditis, coágulos sanguíneos y daños neurológicos con la vacunación contra el COVID-19, pero ahora también se habla de nuevas erupciones cutáneas. Un artículo de Seirafianpour et al resumió 180 artículos/informes impresionantes de los primeros siete meses de la campaña de vacunación solamente, describiendo en tablas exhaustivas la amplia gama de erupciones cutáneas y trastornos de las superficies mucosas (boca/nariz/ano) donde la proteína pico, o Spike de la inyección y/o los mediadores inflamatorios provocan manifestaciones dermatológicas. Nunca ha habido una inyección que tenga este grado de toxicidad dermatológica grave y bien documentada.
Al final del artículo hemos incluido 480 estudios más, revisados por pares sobre efectos adversos de la Inyección K0 B1T en la piel
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111423/pdf/DTH-35-0.pdf
Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Dermatol Ther. 2022 Jun;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 Apr 11. PMID: 35316551; PMCID: PMC9111423.Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. Una revisión sistemática sobre presentaciones mucocutáneas después de la vacunación contra el COVID-19 y recomendaciones de expertos sobre la vacunación de importantes trastornos dermatológicos inmunomediados. Dermatol Ther. 2022 junio;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 11 de abril. PMID: 35316551; PMCID: PMC9111423.
Uno de los principales hallazgos de los autores es: “Los efectos secundarios se informaron con mayor frecuencia dentro de los primeros 3 días después de la vacunación, pero también hubo algunos estudios que informaron reacciones adversas tardías, hasta 4 semanas después de la vacunación.
La duración de las reacciones varió desde casi 1 día con mayor frecuencia hasta 4 semanas o más. La localización más frecuente de las lesiones mucocutáneas fue en miembros superiores (lugar de inyección), tronco y cara.
Casi la mitad de estos estudios informaron las comorbilidades de los participantes. Las comorbilidades más comúnmente reportadas fueron:
- hipertensión,
- antecedentes de COVID-19,
- diabetes mellitus,
- trastornos cardiovasculares,
- autoinmunes,
- reumatológicos o
- alérgicos,
- neoplasias malignas,
- obesidad y
- anafilaxia”.
https://openvaers.com/covid-data/shingles
Este estudio deja en claro que si uno tiene un trastorno autoinmune o alérgico al inicio, entonces una inyección COVID-19 está causando un gran problema. Otras condiciones enumeradas deberían servir como advertencias similares.
Muchas de estas erupciones son duraderas, requerirán citas dermatológicas y, en algunos casos, necesitarán infusiones intravenosas intermitentes y costosas. Se ha recomendado que las inyecciones se retiren del mercado y en este momento no se pueden recomendar a nadie.
Si encuentra “ este artículo útil suscríbase como miembro de nuestro equipo para apoyarnos y en conjunto podamos aclarar el tema en discusiones con familiares, amigos, funcionarios y empleadores. L Muchas gracias. Puede Apoyarnos en https://cienciaysaludnatural.com/colaboracion
Colabore por favor con nosotros para que podamos incluir mas información y llegar a más personas: contribución en mercado pago o paypal por única vez, Muchas Gracias!
Via PAYPAL: Euros o dólares click aqui
ARGENTINA 10.000$ar https://mpago.la/1srgnEY
5.000$ar https://mpago.la/1qzSyt9
1.000$ar https://mpago.la/1Q1NEKM
Solicite nuestro CBU contactenos
480 Estudios más sobre efectos adversos de la Inyección K0 B1T en la piel
| https://pubmed.ncbi.nlm.nih.gov/34742927/ | A localised vasculitic-like skin rash following the second dose of COVID-19 vaccine – PubMed | Abobaker et al |
| https://pubmed.ncbi.nlm.nih.gov/33783017/ | Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine | Ackerman et al |
| https://pubmed.ncbi.nlm.nih.gov/34686374/ | Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine | Agharbi et al |
| https://pubmed.ncbi.nlm.nih.gov/35218057/ | Cutaneous reactions after coronavirus disease 2019 vaccination: Summary of 20 Japanese cases | Akatsuka et al |
| https://pubmed.ncbi.nlm.nih.gov/35187768/ | Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation | Akoglu |
| https://pubmed.ncbi.nlm.nih.gov/34236714/ | Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence? | Aktas & Ertuğrul |
| https://pubmed.ncbi.nlm.nih.gov/35371700/ | Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine | Alamri et al |
| https://pubmed.ncbi.nlm.nih.gov/34391695/ | Palms and soles itchiness as a side effect of COVID-19 vaccination | Al-Ansari et al |
| https://pubmed.ncbi.nlm.nih.gov/35386174/ | Lichen Planus Eruption Following Oxford-AstraZeneca COVID-19 Vaccine Administration: A Case Report and Review of Literature | Alrawashdeh et al |
| https://pubmed.ncbi.nlm.nih.gov/35251600/ | Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report – PubMed | Alshammari et al |
| https://pubmed.ncbi.nlm.nih.gov/35422564/ | Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine | Alzoabi et al |
| https://pubmed.ncbi.nlm.nih.gov/34545609/ | Skin ulcer at the injection site of BNT162b2 mRNA COVID-19 vaccine | Aoki et al |
| https://pubmed.ncbi.nlm.nih.gov/35449768/ | Morphea in two patients after being infected to and being vaccinated against SARS-CoV-2 infection | Aryanian et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34791786/ | Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration | Atak et al |
| https://pubmed.ncbi.nlm.nih.gov/35067994/ | Reply to ‘The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?’ by Damiani G et al | Avallone et al |
| https://pubmed.ncbi.nlm.nih.gov/34997985/ | Inverse lichen planus post Oxford-AstraZeneca COVID-19 vaccine | Awada et al |
| https://pubmed.ncbi.nlm.nih.gov/34835143/ | Sweet Syndrome Following SARS-CoV2 Vaccination | Baffa et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35308065/ | A case report of anti-P200 pemphigoid following COVID-19 vaccination | Bailly-Caillé et al |
| https://pubmed.ncbi.nlm.nih.gov/34748655/ | Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review | Balogun et al |
| https://pubmed.ncbi.nlm.nih.gov/35062748/ | Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy Adult | Barry et al |
| https://pubmed.ncbi.nlm.nih.gov/34272069/ | [Eczematiform eruption after Pfizer-BioNTech COVID-19 vaccine] | Bekkali et al |
| https://pubmed.ncbi.nlm.nih.gov/34423105/ | Lichen striatus post-COVID-19 vaccination | Belina et al |
| https://pubmed.ncbi.nlm.nih.gov/35288926/ | SARS-CoV-2 vaccine induced Sweet syndrome : a case report | Ben Rejeb et al |
| https://pubmed.ncbi.nlm.nih.gov/34473839/ | Atypical erythema multiforme related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine | Bonino et al |
| https://pubmed.ncbi.nlm.nih.gov/34547125/ | Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiforme | Borg et al |
| https://pubmed.ncbi.nlm.nih.gov/34606671/ | Pfizer/BioNTech-associated perniosis in two young adults with re-challenge evidence | Brooks SG et al |
| https://pubmed.ncbi.nlm.nih.gov/35224170/ | New-onset of vitiligo in a child following COVID-19 vaccination | Bukhari |
| https://pubmed.ncbi.nlm.nih.gov/35148438/ | Reply to «COVID vaccine-induced lichen planus on areas previously affected by vitiligo» | Bularca et al |
| https://pubmed.ncbi.nlm.nih.gov/34837354/ | Cutaneous reactions to COVID-19 vaccine at the dermatology primary care | Burlando et al |
| https://pubmed.ncbi.nlm.nih.gov/34902185/ | Reply to ‘New-onset cutaneous lichen planus triggered by COVID-19 vaccination’ by Merhy et al | Camela et al |
| https://pubmed.ncbi.nlm.nih.gov/34236735/ | Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine | Cameli et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34214206/ | AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report | Capassoni et al |
| https://pubmed.ncbi.nlm.nih.gov/35266259/ | Vitiligo worsened following the second dose of mRNA SARS-CoV-2 vaccine | Caroppo et al |
| https://pubmed.ncbi.nlm.nih.gov/34254291/ | Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases | Català et al |
| https://pubmed.ncbi.nlm.nih.gov/35455281/ | Development of Flat Warts on the Cheeks after BioNTech-Pfizer BNT162b2 Vaccine: Is There a Correlation? | Cazzato et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35434826/ | Erythema nodosum induced by Covid-19 Pfizer-BioNTech mRNA vaccine: A case report and brief literature review | Chahed et al |
| https://pubmed.ncbi.nlm.nih.gov/34751491/ | Sudden onset of vitiligo after COVID-19 vaccine | Ciccarese et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35247654/ | Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination | Cole et al |
| https://pubmed.ncbi.nlm.nih.gov/34557622/ | Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine | Colia et al |
| https://pubmed.ncbi.nlm.nih.gov/33834563/ | Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single-centre case series | Corbeddu et al |
| https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8444733/ | Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature – PMC | Coto‐Segura et al |
| https://pubmed.ncbi.nlm.nih.gov/33982814/ | Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine | Cyrenn et al |
| https://pubmed.ncbi.nlm.nih.gov/34169578/ | The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? | Damiani et al |
| https://pubmed.ncbi.nlm.nih.gov/33620081/ | ‘Blue toes’ following vaccination with the BNT162b2 mRNA COVID-19 vaccine | Davido et al |
| https://pubmed.ncbi.nlm.nih.gov/34854640/ | [A red and swollen arm after vaccination for covid-19] | De Mik et al |
| https://pubmed.ncbi.nlm.nih.gov/34786801/ | Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy | Dell’Antonia et al |
| https://pubmed.ncbi.nlm.nih.gov/34730195/ | Acute tubulointerstitial nephritis after COVID-19 m-RNA BNT162b2 vaccine | Dheir et al |
| https://pubmed.ncbi.nlm.nih.gov/34953018/ | Lichen planus and lichen planopilaris flare after COVID-19 vaccination | Diab et al |
| https://www.mdpi.com/2076-393X/10/4/602 | Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect? (Breastfeeding Infant AE) Vaccines | Free Full-Text | | Diogo et al |
| https://pubmed.ncbi.nlm.nih.gov/35199304/ | Persistent pruritus following COVID-19 vaccination | Doyle & Watchorn |
| https://pubmed.ncbi.nlm.nih.gov/35237629/ | Case Report: Rowell Syndrome-Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection | Drenovska et al |
| https://pubmed.ncbi.nlm.nih.gov/35133700/ | Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis | Durmus et al |
| https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8447368/ | Widespread purpura annularis telangiectodes following mRNA SARS‐CoV‐2 vaccine – PMC | Falkenhain‐López et al |
| https://pubmed.ncbi.nlm.nih.gov/35211310/ | De novo and relapsing necrotizing vasculitis after COVID-19 vaccination | Fillon et al |
| https://pubmed.ncbi.nlm.nih.gov/33725406/ | Prompt onset of Rowell’s syndrome following the first BNT162b2 SARS-CoV-2 vaccination | Gambichler et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35132838/ | Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination | Gouda et al |
| https://pubmed.ncbi.nlm.nih.gov/34416053/ | ‘COVID vaccine arm’ may present after both mRNA vaccines vaccination | Gregoriou et al |
| https://pubmed.ncbi.nlm.nih.gov/34585371/ | A case of COVID-19 vaccination-associated forme fruste purpura fulminans | Griss et al |
| https://pubmed.ncbi.nlm.nih.gov/33982318/ | Recurrent injection‐site reactions after incorrect subcutaneous administration of a COVID‐19 vaccine | Gyldenløve et al |
| https://pubmed.ncbi.nlm.nih.gov/34762342/ | Linear IgA bullous dermatosis following Oxford AstraZeneca COVID-19 vaccine | Hali F et al |
| https://pubmed.ncbi.nlm.nih.gov/35425676/ | Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Series of Five Cases | Hali Sr ete al |
| https://pubmed.ncbi.nlm.nih.gov/35571457/ | Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine | Han J et al |
| https://pubmed.ncbi.nlm.nih.gov/34934493/ | Lichen planus flare following COVID-19 vaccination: A case report | Herzum et al |
| https://pubmed.ncbi.nlm.nih.gov/33724563/ | Lichen planus arising after COVID-19 vaccination | Hiltun et al |
| https://pubmed.ncbi.nlm.nih.gov/34423106/ | A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology – PubMed | Holmes et al |
| https://pubmed.ncbi.nlm.nih.gov/34379821/ | Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine | Hunjan et al |
| https://pubmed.ncbi.nlm.nih.gov/35293793/ | Leukocytoclastic Vasculitic Rash Following Second Dose of Moderna COVID-19 Vaccine | Ireifej et al |
| https://pubmed.ncbi.nlm.nih.gov/34513435/ | Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine – PubMed | Irvine & Wiles |
| https://pubmed.ncbi.nlm.nih.gov/34546346/ | Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination | Ishizuka et al |
| https://pubmed.ncbi.nlm.nih.gov/33560802/ | Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine | Jedlowski & Jedlowski |
| https://pubmed.ncbi.nlm.nih.gov/33978670/ | Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series | Johnston et al |
| https://pubmed.ncbi.nlm.nih.gov/34455671/ | Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine | Joseph & Chong |
| https://pubmed.ncbi.nlm.nih.gov/34603727/ | New-onset vitiligo following mRNA-1273 (Moderna) COVID-19 vaccination – PubMed | Kaminetzky & Rudikoff |
| https://pubmed.ncbi.nlm.nih.gov/35263820/ | Oral lichen planus following mRNA COVID-19 vaccination | Kaomongkolgit & Sawangarun |
| https://pubmed.ncbi.nlm.nih.gov/34162525/ | «COVID Toes» After mRNA COVID-19 Vaccines | Kelso et al |
| https://pubmed.ncbi.nlm.nih.gov/34242422/ | ‘COVID arm’ – histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine | Kempf et al |
| https://pubmed.ncbi.nlm.nih.gov/34423142/ | Moderna COVID-19 vaccine induced skin rash – PMC | Khalid et al |
| https://pubmed.ncbi.nlm.nih.gov/34751429/ | A case of toxic epidermal necrolysis after ChAdOx1 nCov‐19 (AZD1222) vaccination – PMC | Kherlopian et al |
| https://pubmed.ncbi.nlm.nih.gov/34661942/ | Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech) | Kim MJ et al |
| https://pubmed.ncbi.nlm.nih.gov/35357514/ | [Delayed local reaction with subcutaneous infiltration after vaccination with mRNA-1273-a previously undescribed reaction pattern of COVID arm] | Kofler & Forchhammer |
| https://pubmed.ncbi.nlm.nih.gov/34294590/ | Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report – PubMed | Kong et al |
| https://pubmed.ncbi.nlm.nih.gov/34131967/ | Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine | Krajewski et al |
| https://pubmed.ncbi.nlm.nih.gov/34291477/ | Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination | Kreuter et al |
| https://pubmed.ncbi.nlm.nih.gov/34292611/ | Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination | Larson et al |
| https://pubmed.ncbi.nlm.nih.gov/33914926/ | A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine | Lavery et al |
| https://pubmed.ncbi.nlm.nih.gov/34557507/ | Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination – PubMed | Leerunyakul et al |
| https://pubmed.ncbi.nlm.nih.gov/34131969/ | Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS-CoV-2 | Lesort et al |
| https://pubmed.ncbi.nlm.nih.gov/34120504/ | COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis | Lindgren et al |
| https://pubmed.ncbi.nlm.nih.gov/35130405/ | New-onset cutaneous lupus erythematosus after the COVID-19 vaccine | Liu & Messenger |
| https://pubmed.ncbi.nlm.nih.gov/33893637/ | Pernio after COVID-19 vaccination | Lopez S et al |
| https://pubmed.ncbi.nlm.nih.gov/33855706/ | Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine | López-Valle et al |
| https://pubmed.ncbi.nlm.nih.gov/34590397/ | Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female – PubMed | Majid & Mearaj |
| https://pubmed.ncbi.nlm.nih.gov/35356381/ | Woman with pruritic rash and dermatographism | Malcolm & Shah |
| https://pubmed.ncbi.nlm.nih.gov/35295599/ | Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study | Maronese et al |
| https://pubmed.ncbi.nlm.nih.gov/34936145/ | Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19) | Masseran et al |
| https://pubmed.ncbi.nlm.nih.gov/34048614/ | Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle? | Mazzatenta et al |
| https://pubmed.ncbi.nlm.nih.gov/34210829/ | A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine? | Meara et al |
| https://pubmed.ncbi.nlm.nih.gov/34236718/ | New-onset cutaneous lichen planus triggered by COVID-19 vaccination | Merhy et al |
| https://pubmed.ncbi.nlm.nih.gov/34319363/ | Association of Facial Pustular Neutrophilic Eruption With Messenger RNA-1273 SARS-CoV-2 Vaccine | Merrill et al |
| https://pubmed.ncbi.nlm.nih.gov/35145806/ | Vitiligo Possibly Triggered by COVID-19 Vaccination | Militello et al |
| https://pubmed.ncbi.nlm.nih.gov/35536295/ | Development of delayed dermal hypersensitivity reaction following the second dose of COVID-19 vaccine – A series of 37 cases | Mohta & Sharma |
| https://pubmed.ncbi.nlm.nih.gov/34547138/ | Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine | Montjoye et al |
| https://pubmed.ncbi.nlm.nih.gov/33559733/ | «COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment» | Munavalli et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34676639/ | Generalized dermal hypersensitivity reaction following Moderna COVID-19 vaccination | Myrdal et al |
| https://pubmed.ncbi.nlm.nih.gov/34545973/ | Case of bullous pemphigoid following coronavirus disease 2019 vaccination | Nakamura et al |
| https://pubmed.ncbi.nlm.nih.gov/35137500/ | Figurate purpuric eruption post-COVID-19 vaccination | Namazi et al |
| https://pubmed.ncbi.nlm.nih.gov/34075664/ | Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine | Niebel et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34167874/ | Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations | Ohsawa et al |
| https://pubmed.ncbi.nlm.nih.gov/34931408/ | Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine | Okan & Vural |
| https://pubmed.ncbi.nlm.nih.gov/35455266/ | Frequent Onsets of Cellulitis in Lower Limbs with Lymphedema Following COVID-19 mRNA Vaccination | Okazaki et al |
| https://pubmed.ncbi.nlm.nih.gov/35169602/ | Severe flare of pemphigus vulgaris after first dose of COVID-19 vaccine | Ong et al |
| https://pubmed.ncbi.nlm.nih.gov/34631106/ | Lichenoid cutaneous skin eruption and associated systemic inflammatory response following Pfizer-BioNTech mRNA COVID-19 vaccine administration | Onn & Chang |
| https://pubmed.ncbi.nlm.nih.gov/35097176/ | Palmoplantar lichenoid drug eruption following the administration of Pfizer-BioNTech COVID-19 vaccine | Paolino & Rongioletti |
| https://pubmed.ncbi.nlm.nih.gov/35224780/ | Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab | Pavia et al |
| https://pubmed.ncbi.nlm.nih.gov/34533265/ | Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review | Pedrazini & da Silva |
| https://pubmed.ncbi.nlm.nih.gov/34119340/ | Bullous pemphigoid and COVID-19 vaccine | Pérez-López et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35331228/ | Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases | Pertruzzi et al |
| https://pubmed.ncbi.nlm.nih.gov/33914966/ | BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2 | Piccolo et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34547122/ | COVID vaccine-induced lichen planus on areas previously affected by vitiligo | Piccolo et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34750923/ | «Covid arm»: Abnormal side effect after Moderna COVID-19 vaccine | Picone et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35167108/ | A Case of New-Onset Lichen Planus after COVID-19 Vaccination | Picone et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/33904168/ | Chilblain lesions after COVID-19 mRNA vaccine | Pileri et al |
| https://pubmed.ncbi.nlm.nih.gov/34983709/ | Delayed systemic urticarial reactions following mRNA COVID-19 vaccination | Pitlick et al |
| https://pubmed.ncbi.nlm.nih.gov/34570195/ | Post-vaccination COVID Toes (Chilblains) Exacerbated by Rituximab Infusion Suggests Interferon Activation as Mechanism | Qiao et al |
| https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112292/ | Acral hemorrhages after administration of the second dose of the SARS-CoV-2 vaccine. A post-vaccination reaction? – PMC | Ramos et al |
| https://pubmed.ncbi.nlm.nih.gov/35291527/ | Vesicular Rash Following Immunisation With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine: Vaccine Related or Coincidence? | Rashid MRA et al |
| https://pubmed.ncbi.nlm.nih.gov/34928536/ | SCLE manifestation after mRNA COVID-19 vaccination | Rechtien et al |
| https://pubmed.ncbi.nlm.nih.gov/34310777/ | New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: clinical images and histopathological study of three cases | Revilla-Nebreda et al |
| https://pubmed.ncbi.nlm.nih.gov/35393710/ | COVID-19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine | Riquelme et al |
| https://pubmed.ncbi.nlm.nih.gov/34617317/ | Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine | Sechi et al |
| https://pubmed.ncbi.nlm.nih.gov/35305031/ | Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthema | Sechi et al |
| https://pubmed.ncbi.nlm.nih.gov/35349766/ | Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from Brazil | Seque et al |
| https://pubmed.ncbi.nlm.nih.gov/34751995/ | Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption | Sernicola et al |
| https://pubmed.ncbi.nlm.nih.gov/34606669/ | Development of oral lichen planus after COVID-19 vaccination – a rare case report | Sharda et al |
| https://pubmed.ncbi.nlm.nih.gov/34109263/ | Localized and generalized urticarial allergic dermatitis secondary to SARS-CoV-2 vaccination in a series of 6 patients | Sidlow et al |
| https://pubmed.ncbi.nlm.nih.gov/34169588/ | Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2 | Solimani et al |
| https://pubmed.ncbi.nlm.nih.gov/34396420/ | Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report | Souaid et al |
| https://pubmed.ncbi.nlm.nih.gov/35224171/ | Sclerotic skin disease development following COVID-19 vaccination | Sprow et al |
| https://pubmed.ncbi.nlm.nih.gov/34351606/ | Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2 | Sprute et al |
| https://pubmed.ncbi.nlm.nih.gov/35191544/ | Exacerbation of systemic lupus erythematosus after receiving mRNA-1273-based coronavirus disease 2019 vaccine | Sugimoto et al |
| https://pubmed.ncbi.nlm.nih.gov/34897823/ | Koebner phenomenon with lichen planus in an area of previous vitiligo after COVID-19 vaccination and the creation of a locus minoris resistentiae | Tatu et al |
| https://pubmed.ncbi.nlm.nih.gov/33900629/ | Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination | Temmiz et al |
| https://pubmed.ncbi.nlm.nih.gov/34459036/ | Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines | Tihy et al |
| https://pubmed.ncbi.nlm.nih.gov/34275656/ | Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination | Tomayko et al |
| https://pubmed.ncbi.nlm.nih.gov/34543493/ | Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26.COV2.S) | Troeltzsch et al |
| https://pubmed.ncbi.nlm.nih.gov/35152540/ | Newly-developed vitiligo following COVID-19 mRNA vaccine | Uğurer et al |
| https://pubmed.ncbi.nlm.nih.gov/34726187/ | Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality? | Ungari & Pezzarossa |
| https://pubmed.ncbi.nlm.nih.gov/34547113/ | Early atypical injection‐site reactions to COVID‐19 vaccine: a case series | Vaccaro et al |
| https://pubmed.ncbi.nlm.nih.gov/35167784/ | Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine | Valk & Bender |
| https://pubmed.ncbi.nlm.nih.gov/34588156/ | Viral-like Reaction or Hypersensitivity? Erythema Multiforme Minor Reaction and Moderate Eosinophilia After the Pfizer-BioNTech BNT162b2 (mRNA-Based) SARS-CoV-2 Vaccine | Vecillas et al |
| https://pubmed.ncbi.nlm.nih.gov/34100306/ | Late-onset cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine in an immunocompromised patient | Weinstock-Guttman & Jakimovski |
| https://pubmed.ncbi.nlm.nih.gov/34676438/ | [Erythema multiforme following COVID-19 vaccination (BNT162b2)] | Wunderlich & Dirschka |
| https://pubmed.ncbi.nlm.nih.gov/34862669/ | Flare-up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination | Yatsuzuka et al |
| https://pubmed.ncbi.nlm.nih.gov/35170156/ | New onset of pemphigus foliaceus following BNT162b2 vaccine | Yıldırıcı et al |
| https://pubmed.ncbi.nlm.nih.gov/34547137/ | A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine | Young J et al |
| https://pubmed.ncbi.nlm.nih.gov/34817862/ | Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine | Žagar et al |
| https://pubmed.ncbi.nlm.nih.gov/35147269/ | New-onset lichen planus arising after COVID-19 vaccination | Zagaria et al |
| https://pubmed.ncbi.nlm.nih.gov/35174595/ | Lichen Ruber Planus occurring after SARS-CoV-2 vaccination | Zengarini et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34807495/ | Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis | Zengarini et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34726769/ | Bilateral giant cell arteritis with skin necrosis following SARS-CoV-2 vaccination | Gamblichler et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/33991162/ | 20 Post-COVID-19 vaccine-related shingles cases seen at the Las Vegas Dermatology clinic and sent to us via social media | Lee C et al |
| https://pubmed.ncbi.nlm.nih.gov/34327795/ | Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine | Vassallo et al |
| https://pubmed.ncbi.nlm.nih.gov/35306713/ | SARS-CoV-2 vaccination-induced cutaneous vasculitis: Report of two new cases and literature review | Abdelmaksoud et al |
| https://pubmed.ncbi.nlm.nih.gov/35141951/ | Reproducible leukocytoclastic vasculitis following severe acute respiratory syndrome coronavirus 2 vaccination | Gambichler et al (3) |
| https://pubmed.ncbi.nlm.nih.gov/34853744/ | Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine | Shahrigharahkoshan et al |
| https://pubmed.ncbi.nlm.nih.gov/34599716/ | Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination | Liang et al |
| https://pubmed.ncbi.nlm.nih.gov/34236717/ | Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine | Falkenhain-López et al |
| https://pubmed.ncbi.nlm.nih.gov/34247902/ | Henoch-Schönlein purpura presenting post COVID-19 vaccination | Hines et al |
| https://pubmed.ncbi.nlm.nih.gov/35361289/ | Dermatomyositis post vaccine against SARS-COV2 | Coronel et al |
| https://pubmed.ncbi.nlm.nih.gov/34482558/ | Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination | Wantavornprasert et al |
| https://pubmed.ncbi.nlm.nih.gov/34399001/ | Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination | Lim & Wylie |
| https://pubmed.ncbi.nlm.nih.gov/34398977/ | De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine | Elamin et al |
| https://pubmed.ncbi.nlm.nih.gov/35306720/ | Generalized erythrodermic psoriasis triggered by vaccination against severe acute respiratory syndrome Coronavirus 2 | Tran TB et al |
| https://pubmed.ncbi.nlm.nih.gov/35299937/ | A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasis | Norimatsu & Norimatsu |
| https://pubmed.ncbi.nlm.nih.gov/35285114/ | A case of new-onset acute generalized pustular psoriasis following Pfizer-BioNTech COVID-19 vaccine | Frioui et al |
| https://pubmed.ncbi.nlm.nih.gov/35315189/ | Pustular rash triggered by Pfizer-BioNTech COVID-19 vaccination: A case report | Rouai et al |
| https://pubmed.ncbi.nlm.nih.gov/34522741/ | Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine | Perna et al |
| https://pubmed.ncbi.nlm.nih.gov/35066960/ | Exacerbations of generalized pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris after mRNA COVID-19 vaccine: A report of three cases | Durmaz et al |
| https://pubmed.ncbi.nlm.nih.gov/35344627/ | Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccine | lahouel et al |
| https://pubmed.ncbi.nlm.nih.gov/35106762/ | Cutaneous polyarteritis nodosa following ChAdOx1 nCoV-19 vaccination | Su HA et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34696186/ | Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report | Sirufo et al |
| https://pubmed.ncbi.nlm.nih.gov/34129749/ | Localized cutaneous reaction to an mRNA COVID-19 vaccine | Edriss et al |
| https://pubmed.ncbi.nlm.nih.gov/34250736/ | Erythema migrans-like rash after Moderna vaccine: An uncommon type of «COVID arm» | Zengarini et al (3) |
| https://pubmed.ncbi.nlm.nih.gov/34813953/ | Delayed hypersensitivity to the Comirnaty coronavirus disease 2019 vaccine presenting with pneumonitis and rash | Stoyanov et al |
| https://pubmed.ncbi.nlm.nih.gov/33657292/ | Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 | Blumenthal et al |
| https://pubmed.ncbi.nlm.nih.gov/33882228/ | Delayed Large Local Reactions to mRNA Vaccines | Baeck et al |
| https://pubmed.ncbi.nlm.nih.gov/34459023/ | Five Japanese cases of delayed large local reactions to coronavirus disease 2019 vaccines | Sato |
| https://pubmed.ncbi.nlm.nih.gov/34603964/ | Delayed large pruritic eruption to the BNT162b2 mRNA vaccine | Terashima |
| https://pubmed.ncbi.nlm.nih.gov/34310755/ | A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine | Pasternack & Pohjavaara |
| https://pubmed.ncbi.nlm.nih.gov/34657348/ | Response to ‘A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine’ | Kouki et al |
| https://pubmed.ncbi.nlm.nih.gov/34166540/ | Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’? | Kim JE et al |
| https://pubmed.ncbi.nlm.nih.gov/34698094/ | Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines | Niebel et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/35308066/ | Erythema nodosum after COVID-19 vaccination in a pediatric patient | Hafer et al |
| https://pubmed.ncbi.nlm.nih.gov/34662466/ | Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccine | Cameli et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34934549/ | First Case of Erythema Nodosum Associated With Pfizer Vaccine | Aly et al |
| https://pubmed.ncbi.nlm.nih.gov/34977819/ | Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine | Wu X et al |
| https://pubmed.ncbi.nlm.nih.gov/34416052/ | Flagellate purpura associated with COVID-19 vaccination | Heck et al |
| https://pubmed.ncbi.nlm.nih.gov/35296923/ | [Pityriasis rubra pilaris after COVID-19 vaccination: causal relationship or coincidence?] | Bramhoff et al |
| https://pubmed.ncbi.nlm.nih.gov/35284230/ | Fasciitis of the lower leg after COVID-19 vaccination | Ide et al |
| https://pubmed.ncbi.nlm.nih.gov/35194793/ | Unusual contact dermatitis after SARS-CoV-2 vaccinations | Jungwirth et al |
| https://pubmed.ncbi.nlm.nih.gov/34913043/ | Shoulder injury related to COVID-19 vaccine administration: a case report | Wharton et al |
| https://pubmed.ncbi.nlm.nih.gov/34402098/ | Two cases of mild systemic adverse skin eruption after coronavirus disease 2019 vaccination | Nanamori et al |
| https://pubmed.ncbi.nlm.nih.gov/34363258/ | Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine) | Juay & Chandran |
| https://pubmed.ncbi.nlm.nih.gov/34337117/ | Skin necrosis at both COVID-19 vaccine injection sites | Gruenstein & Levitt |
| https://pubmed.ncbi.nlm.nih.gov/34839563/ | Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccination | Kuzumi et al |
| https://pubmed.ncbi.nlm.nih.gov/34358176/ | Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives | Cazzato et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34293500/ | Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19 | Guerrero et al |
| https://pubmed.ncbi.nlm.nih.gov/33864927/ | «COVID Arm»: Very delayed large injection site reactions to mRNA COVID-19 vaccines | Ramos & Kelso |
| https://pubmed.ncbi.nlm.nih.gov/34102322/ | Delayed large local reaction to the adenovirus-vectored (ChAdOx1) vaccine | Grobusch et al |
| https://pubmed.ncbi.nlm.nih.gov/34276178/ | Delayed Skin Rash After Receiving SARS-CoV-2 mRNA Moderna Vaccine | Papamanoli et al |
| https://pubmed.ncbi.nlm.nih.gov/34236729/ | Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine | Leasure et al |
| https://pubmed.ncbi.nlm.nih.gov/34236711/ | Vesiculobullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature | Coto-Segura et al |
| https://pubmed.ncbi.nlm.nih.gov/34129694/ | Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccine | Shin E et al |
| https://pubmed.ncbi.nlm.nih.gov/34086881/ | Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees | Jacobson et al |
| https://pubmed.ncbi.nlm.nih.gov/34031953/ | Local reactions to the second dose of the BNT162 COVID-19 vaccine | Tammaro et al |
| https://pubmed.ncbi.nlm.nih.gov/33996313/ | BCG Scar Local Skin Inflammation as a Novel Reaction Following mRNA COVID-19 Vaccines in Two International Healthcare Workers | Lopatynsky-Reyes et al |
| https://pubmed.ncbi.nlm.nih.gov/34930152/ | Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports | Mohamed L et al |
| https://pubmed.ncbi.nlm.nih.gov/35305036/ | Transient inflammation in surgical scars following Covid-19 mRNA vaccination | Ferreli et al |
| https://pubmed.ncbi.nlm.nih.gov/34344774/ | Bacillus Calmette-Guérin scar flare after an mRNA SARS-CoV-2 vaccine | Lim D WT et al |
| https://pubmed.ncbi.nlm.nih.gov/35398905/ | Stevens-Johnson syndrome precipitated by Moderna Inc. COVID-19 vaccine: a case-based review of literature comparing vaccine and drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis | Padniewski et al |
| https://pubmed.ncbi.nlm.nih.gov/35274363/ | Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19) | Salem et al |
| https://pubmed.ncbi.nlm.nih.gov/34582621/ | Oral pemphigus after COVID-19 vaccination | Thongprasom et al |
| https://pubmed.ncbi.nlm.nih.gov/34718079/ | Vulvar Aphthous Ulcer Following Pfizer-BioNTech COVID-19 Vaccine – A Case Report | Drucker et al |
| https://pubmed.ncbi.nlm.nih.gov/34706274/ | Vulvar Aphthous Ulcer in an Adolescent After Pfizer-BioNTech (BNT162b2) COVID-19 Vaccination | Wojcicki & O’Brien |
| https://pubmed.ncbi.nlm.nih.gov/34888935/ | Vulvar aphthous ulcer after COVID-19 vaccination | Popatia & Chiu |
| https://pubmed.ncbi.nlm.nih.gov/35413297/ | Acute Genital Ulceration After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination and Infection | Hsu T et al |
| https://pubmed.ncbi.nlm.nih.gov/35114426/ | Ulcers on the bilateral palate mucosa following mRNA-based vaccination for coronavirus disease 2019 (COVID-19): A case report | Maeda et al |
| https://pubmed.ncbi.nlm.nih.gov/35260129/ | Various painful oral adverse reactions following COVID-19 vaccination: a case series | Chun Y et al |
| https://pubmed.ncbi.nlm.nih.gov/34753210/ | Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination | Cinotti et al |
| https://pubmed.ncbi.nlm.nih.gov/34487570/ | Psoriasis exacerbation after first dose of AstraZeneca coronavirus disease 2019 vaccine | Fang et al |
| https://pubmed.ncbi.nlm.nih.gov/34231301/ | Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitor | Mieczkowska et al |
| https://pubmed.ncbi.nlm.nih.gov/34363647/ | Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre | Sotiriou et al |
| https://pubmed.ncbi.nlm.nih.gov/35015916/ | COVID vaccine-induced pustular psoriasis in patients with previous plaque type psoriasis | Piccolo et al |
| https://pubmed.ncbi.nlm.nih.gov/34309932/ | New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report | Lehmann et al |
| https://pubmed.ncbi.nlm.nih.gov/34236728/ | New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination | Quattrini et al |
| https://pubmed.ncbi.nlm.nih.gov/34348912/ | Remitting seronegative symmetrical synovitis with pitting oedema following BNT162b2 mRNA COVID-19 vaccination | Parperis & Constantinou |
| https://pubmed.ncbi.nlm.nih.gov/35236680/ | Marked increase of interferon-β after BNT162b2 mRNA vaccination: a case of polyarthritis with pleurisy | Shimagami et al |
| https://pubmed.ncbi.nlm.nih.gov/35079580/ | Psoriatic flare following Oxford-AstraZeneca ChAdOx1 COVID-19 and influenza vaccines | The & Leow |
| https://pubmed.ncbi.nlm.nih.gov/34350668/ | Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases | Nagrani et al |
| https://pubmed.ncbi.nlm.nih.gov/34713443/ | De novo guttate psoriasis following coronavirus disease 2019 vaccination | Song WJ et al |
| https://pubmed.ncbi.nlm.nih.gov/35176180/ | A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine | Ohmura et al |
| https://pubmed.ncbi.nlm.nih.gov/35004790/ | Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single Center | Huang & Tsai |
| https://pubmed.ncbi.nlm.nih.gov/35170153/ | Erythrodermic psoriasis eruption associated with SARS-CoV-2 vaccination | Nia et al |
| https://pubmed.ncbi.nlm.nih.gov/34363731/ | Pityriasis rosea following SARS-CoV-2 vaccination: A case series | Temiz et al |
| https://pubmed.ncbi.nlm.nih.gov/34237178/ | Pityriasis rosea developing after COVID-19 vaccination | Marcantonio-Santa Cruz et al |
| https://pubmed.ncbi.nlm.nih.gov/34110010/ | Pityriasis rosea after mRNA COVID-19 vaccination | Abdullah et al |
| https://pubmed.ncbi.nlm.nih.gov/34740803/ | Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination | Shin SH et al |
| https://pubmed.ncbi.nlm.nih.gov/34165237/ | Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male | Adya et al |
| https://pubmed.ncbi.nlm.nih.gov/33904157/ | Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination | Carballido Vázquez & Morgado |
| https://pubmed.ncbi.nlm.nih.gov/34435935/ | Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine | Cohen et al |
| https://pubmed.ncbi.nlm.nih.gov/35156062/ | Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature | Buckley et al |
| https://pubmed.ncbi.nlm.nih.gov/35012825/ | Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review | Wang CS et al |
| https://pubmed.ncbi.nlm.nih.gov/34585750/ | Atypical pityriasis rosea associated with mRNA COVID-19 vaccine | Bostan & Jarbou |
| https://pubmed.ncbi.nlm.nih.gov/35518792/ | Inverse pityriasis rosea secondary to COVID-19 vaccination | Fenner et al |
| https://pubmed.ncbi.nlm.nih.gov/34762355/ | Benign cutaneous reactions post-COVID-19 vaccination: A case series of 16 patients from a tertiary care center in India | Agarwal et al |
| https://pubmed.ncbi.nlm.nih.gov/34436620/ | Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination | Armoni-Weiss et al |
| https://pubmed.ncbi.nlm.nih.gov/35211316/ | De novo IgA vasculitis following adenovirus-based SARS-CoV-2 vaccination | Oniszczuk et al |
| https://pubmed.ncbi.nlm.nih.gov/33998677/ | Recurrent varicella following SARS-CoV-2 vaccination with BNT162b2 | Nanova et al |
| https://pubmed.ncbi.nlm.nih.gov/35429051/ | Disseminated herpes zoster in an immune-competent patient after SARS-CoV-2 vaccine (BNT162b2 Comirnaty, Pfizer) | Zengarini et al (4) |
| https://pubmed.ncbi.nlm.nih.gov/34121663/ | Hypersensitivity to Covid-19 Vaccine Confirmed by a Positive Skin Test Result: A Case Report | Pérez-Codesido et al |
| https://pubmed.ncbi.nlm.nih.gov/34132638/ | Immediate-Type Hypersensitivity to Polyethylene Glycol (PEG) and a PEG-Containing COVID-19 Vaccine Revealed by Intradermal Testing | Pickert et al |
| https://pubmed.ncbi.nlm.nih.gov/35664444/ | Vaccine Toes Are the New COVID Toes | Hodge et al |
| https://pubmed.ncbi.nlm.nih.gov/35256820/ | Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination | Lopez ED et al |
| https://pubmed.ncbi.nlm.nih.gov/35373779/ | Severe injection site reaction ensuing the first dose of mRNA COVID-19 vaccine: a case report | Pierobon et al |
| https://pubmed.ncbi.nlm.nih.gov/35252516/ | COVID-19 vaccine-associated dermatomyositis | Wu M et al |
| https://pubmed.ncbi.nlm.nih.gov/35049235/ | Transient lower extremity lymphedema following COVID-19 vaccination: A case report | Chung JH et al |
| https://pubmed.ncbi.nlm.nih.gov/34920834/ | The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin | Magro et al |
| https://pubmed.ncbi.nlm.nih.gov/35355380/ | Dermatomyositis following COVID-19 vaccination | Venkateswaran et al |
| https://pubmed.ncbi.nlm.nih.gov/35223429/ | Post-COVID-19 vaccination shoulder abscess and pleuroparenchymal pulmonary lesion due to Burkholderia pseudomallei | Mohanty et al |
| https://pubmed.ncbi.nlm.nih.gov/34310763/ | Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2 | Guzmán-Pérez et al |
| https://pubmed.ncbi.nlm.nih.gov/34363713/ | Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: a case series from the Philippines | Yu JN et al |
| https://pubmed.ncbi.nlm.nih.gov/34703816/ | Acute urticarial rash after COVID-19 vaccination containing Polysorbate 80 | Burlando et al |
| https://pubmed.ncbi.nlm.nih.gov/35470099/ | Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report | Lellig et al |
| https://pubmed.ncbi.nlm.nih.gov/34384729/ | Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case report | Elboraey & Essa |
| https://pubmed.ncbi.nlm.nih.gov/35133674/ | Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccine | Aimo et al |
| https://pubmed.ncbi.nlm.nih.gov/34540442/ | Toxic Epidermal Necrolysis Post COVID-19 Vaccination – First Reported Case | Bakir et al |
| https://pubmed.ncbi.nlm.nih.gov/34416058/ | A Bullous Eruption following the Pfizer-BioNTech COVID-19 vaccination | D’Cruz et al |
| https://pubmed.ncbi.nlm.nih.gov/34524252/ | Transient Eyelid Edema Following COVID-19 Vaccination | Austria et al |
| https://pubmed.ncbi.nlm.nih.gov/34692313/ | Chronic Spontaneous Urticaria After COVID-19 Vaccine | Thomas J et al |
| https://pubmed.ncbi.nlm.nih.gov/35284208/ | Chronic spontaneous urticaria following ChAdOx1-S COVID-19 vaccination | Suan & Lee |
| https://pubmed.ncbi.nlm.nih.gov/34857596/ | COVID-19 vaccine-induced cellulitis and myositis | Ramalingam et al |
| https://pubmed.ncbi.nlm.nih.gov/34934701/ | Delayed-type hypersensitivity skin reaction to Covid-19 vaccine | Robb & Robb |
| https://pubmed.ncbi.nlm.nih.gov/34611073/ | COVID Arm After Moderna Booster in Healthcare Worker: A Case Report | Saifuddin et al |
| https://pubmed.ncbi.nlm.nih.gov/34153381/ | Radiation Recall Phenomenon Following COVID-19 Vaccination | Stewart & McDowell |
| https://pubmed.ncbi.nlm.nih.gov/35103229/ | Breast Radiation Recall Phenomenon After Astra-Zeneca COVID-19 Vaccine: A Case Series | Marples et al |
| https://pubmed.ncbi.nlm.nih.gov/33677050/ | COVID-19 Vaccine-Induced Radiation Recall Phenomenon | Soyfer et al |
| https://pubmed.ncbi.nlm.nih.gov/35101198/ | In Regard to Soyfer et al | Ebner et al |
| https://pubmed.ncbi.nlm.nih.gov/35036285/ | Radiation recall phenomenon after administration of the mRNA-1273 SARS-CoV-2 vaccine | Ishikawa et al |
| https://pubmed.ncbi.nlm.nih.gov/34739397/ | Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 Vaccination | Hughes NM et al |
| https://pubmed.ncbi.nlm.nih.gov/34416044/ | Two cases of papulo-pustular rosacea-like eruptions following COVID-19 vaccinations | Ciccarese et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34951399/ | Multiform Erythema After COVID-19 mRNA Vaccination | Majenka et al |
| https://pubmed.ncbi.nlm.nih.gov/35615160/ | Case series ( Journal of The American Academy of Dermatology Cases Reports) Chronic spontaneous urticaria following COVID-19 vaccination | de Montjoye et al |
| https://pubmed.ncbi.nlm.nih.gov/34427024/ | Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: A report of two cases | Bostan E et ak |
| https://pubmed.ncbi.nlm.nih.gov/34937807/ | Delayed-type hypersensitivity reactions to Pfizer BioNTech SARS-CoV-2 vaccine | Beyaz et al |
| https://pubmed.ncbi.nlm.nih.gov/35097177/ | Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series | Karatas et al |
| https://pubmed.ncbi.nlm.nih.gov/34693548/ | Annular plaques mimicking Rowell’s syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon? | Niebel et al (3) |
| https://pubmed.ncbi.nlm.nih.gov/34611542/ | Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine | Ricardo & Lipner |
| https://pubmed.ncbi.nlm.nih.gov/34978352/ | Sarcoidal immune reaction following SARS-CoV-2 vaccination | Rached et al |
| https://pubmed.ncbi.nlm.nih.gov/35499440/ | An acute, ulcerative, sarcoidal tattoo reaction following SARS-CoV-2 mRNA-1273 vaccination | Manci et al |
| https://pubmed.ncbi.nlm.nih.gov/34895746/ | Cutaneous vasculitis due to COVID-19 vaccination | Gázquez Aguilera et al |
| https://pubmed.ncbi.nlm.nih.gov/34759023/ | Nicolau Syndrome After Glatiramer Acetate Injection in Close Proximity to Administration of SARS-CoV-2 mRNA Vaccine | Sy etal |
| https://pubmed.ncbi.nlm.nih.gov/35073431/ | Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination | Hung & Chi |
| https://pubmed.ncbi.nlm.nih.gov/34880971/ | Drug-induced lichenoid exanthema by a vaccine against COVID-19 (Vaxzevria) | Ziraldo et al |
| https://pubmed.ncbi.nlm.nih.gov/35522122/ | Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination | Ikediobi et al |
| https://pubmed.ncbi.nlm.nih.gov/35022253/ | Post BNT162b2 mRNA COVID-19 vaccination Henoch-Schӧnlein Pupura | Wang SSY |
| https://pubmed.ncbi.nlm.nih.gov/35431308/ | Erythema Multiforme after BNT162b2 Vaccination | Katayama & Ota |
| https://pubmed.ncbi.nlm.nih.gov/35079635/ | Perniosis-like lesions after vaccination with mRNA against COVID-19 | Pérez-López et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/35131890/ | Development of anti-NXP2 dermatomyositis following Comirnaty COVID-19 vaccination | Lee AYS et al |
| https://pubmed.ncbi.nlm.nih.gov/35075691/ | Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre | Koumaki et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35661906/ | Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review | Gonzalez D et al |
| https://pubmed.ncbi.nlm.nih.gov/34776189/ | Effect of gentle exercises on injection site reaction after Covid-19 vaccination. A case report | Kalia |
| https://pubmed.ncbi.nlm.nih.gov/35584258/ | Lymphomatoid papulosis (LyP) after AZD1222 and BNT162b2 COVID-19 vaccines | Koumaki et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/33974494/ | Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination | Brumfiel et al |
| https://pubmed.ncbi.nlm.nih.gov/34228815/ | Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination | Gambicher et al (4) |
| https://pubmed.ncbi.nlm.nih.gov/34478204/ | Cutaneous adverse effects and contraindications to COVID-19 vaccination; four cases and an illustrative review from an Asian country | Choi E et al |
| https://pubmed.ncbi.nlm.nih.gov/35607272/ | Cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine | Luo & Oakley |
| https://pubmed.ncbi.nlm.nih.gov/35583958/ | New onset of psoriasis following COVID-19 vaccination | Tran TNA et al |
| https://pubmed.ncbi.nlm.nih.gov/35073411/ | A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteins | Metin & Celepeli |
| https://pubmed.ncbi.nlm.nih.gov/35751559/ | Cutaneous leukocytoclastic vasculitis following COVID-19 vaccination with Ad26.COV2.S vaccine: a case report and literature review | Betetto et al |
| https://pubmed.ncbi.nlm.nih.gov/35698236/ | Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature | Paparella et al |
| https://pubmed.ncbi.nlm.nih.gov/35613221/ | Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses | Eyer-Silva & Leme |
| https://pubmed.ncbi.nlm.nih.gov/35606031/ | Erythema multiforme in a young adult following COVID-19 infection and vaccination in Tanzania | Manji et al |
| https://pubmed.ncbi.nlm.nih.gov/35373396/ | Histopathological analysis of skin reactions after coronavirus disease 2019 vaccination: Increment in number of infiltrated plasmacytoid dendritic cell | Watanabe H et al |
| https://pubmed.ncbi.nlm.nih.gov/35348281/ | Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature | Singh et al |
| https://pubmed.ncbi.nlm.nih.gov/35278243/ | Case of lichen planus pigmentosus-inversus after Oxford-AstraZeneca COVID-19 vaccine: cause or coincidence? | Sun L et al |
| https://pubmed.ncbi.nlm.nih.gov/35258436/ | Localized lipoatrophy and inadvertent subcutaneous administration of a COVID-19 vaccine | Cook IF |
| https://pubmed.ncbi.nlm.nih.gov/34811862/ | COVID vaccination in patients under treatment with rituximab: A presentation of two cases from Iran and a review of the current knowledge with a specific focus on pemphigus | Hatami et al |
| https://pubmed.ncbi.nlm.nih.gov/35080255/ | Can Covid-19 vaccines cause or exacerbate bullous pemphigoid? A report of seven cases from one center | Afacan et al |
| https://pubmed.ncbi.nlm.nih.gov/34928518/ | Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature review | Pauluzzi et al |
| https://pubmed.ncbi.nlm.nih.gov/34773638/ | Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studies | Gamblichler et al (5) |
| https://pubmed.ncbi.nlm.nih.gov/35031201/ | Morbilliform rashes as an unusual manifestation of vaccine-induced immune thrombotic thrombocytopenia | Yang WT et al |
| https://pubmed.ncbi.nlm.nih.gov/34081806/ | COVID-19 vaccine-induced Stevens-Johnson syndrome | Dash S et al |
| https://pubmed.ncbi.nlm.nih.gov/34877762/ | Papular acrodermatitis of childhood-like eruption triggered by SARS-CoV-2 vaccination: Report of two cases | Villagrasa-Boli et al |
| https://pubmed.ncbi.nlm.nih.gov/34874824/ | Catastrophic antiphospholipid syndrome triggered by mRNA COVID-19 vaccine | Moreno-Torres et al |
| https://pubmed.ncbi.nlm.nih.gov/35365342/ | Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine | Juddoo et al |
| https://pubmed.ncbi.nlm.nih.gov/35099065/ | Leukocytoclastic vasculitis in possible relation to the BNT162b2 mRNA COVID-19 vaccine | Carrillo-Garcia et al |
| https://pubmed.ncbi.nlm.nih.gov/34984777/ | Erythema nodosum after Moderna mRNA-1273 COVID-19 vaccine | Teymour et al |
| https://pubmed.ncbi.nlm.nih.gov/35506318/ | Erythema nodosum after COVID-19 vaccine | Maranini et al |
| https://pubmed.ncbi.nlm.nih.gov/34817063/ | An unusual presentation of pemphigus foliaceus following COVID-19 vaccination | Lua ACY et al |
| https://pubmed.ncbi.nlm.nih.gov/34731529/ | Erythema annulare centrifugum induced by COVID-19 vaccination | Kim JC et al |
| https://pubmed.ncbi.nlm.nih.gov/34720009/ | Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine booster | Dicks & Gray |
| https://pubmed.ncbi.nlm.nih.gov/34699970/ | Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine | Watts MM et al |
| https://pubmed.ncbi.nlm.nih.gov/34663612/ | {Erythema at the site of a Bacille Calmette–Guérin vaccine scar after obtaining a dose of the SARS-CoV-2 messenger RNA vaccine} Érythème au site d’une cicatrice du vaccin bacille de Calmette–Guérin après l’obtention d’une dose du vaccin à ARN messager contre le SRAS-CoV-2 | Lim DWT et al |
| https://pubmed.ncbi.nlm.nih.gov/35567509/ | Marie Antoinette syndrome following COVID-19 vaccination | Baffa et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34291744/ | Unique Case of Urticarial Skin Eruptions After COVID-19 Vaccination | Baraldi et al |
| https://pubmed.ncbi.nlm.nih.gov/34260095/ | Severe cutaneous adverse reaction following COVID-19 vaccination and immunotherapy: a second hit? | Hussain et al |
| https://pubmed.ncbi.nlm.nih.gov/34518832/ | Lymphadenopathy with florid lymphoid and Langerhans cell hyperplasia and hemophagocytosis mimicking lymphoma after COVID-19 mRNA vaccination | Tintle & Chen |
| https://pubmed.ncbi.nlm.nih.gov/33972089/ | COVID arm and PET/FDG imaging | Barriere & Bondouy |
| https://pubmed.ncbi.nlm.nih.gov/33835617/ | Ribonucleic acid COVID-19 vaccine-associated cutaneous adverse drug events: a case series of two patients | Lam M et al |
| https://pubmed.ncbi.nlm.nih.gov/34594203/ | Darier’s Disease Flare following COVID-19 Vaccine | Elbæk et al |
| https://pubmed.ncbi.nlm.nih.gov/33823270/ | Covid-19 vaccine and autoimmunity: Awakening the sleeping dragon | Akinosoglou et al |
| https://pubmed.ncbi.nlm.nih.gov/34145775/ | Skin rashes after SARS-CoV-2 vaccine: which relationship, if any? | Patruno et al |
| https://pubmed.ncbi.nlm.nih.gov/35066922/ | Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccination | Ogawa et al |
| https://pubmed.ncbi.nlm.nih.gov/35049059/ | Massive bullous local reaction following administration of Ad26.COV2.S COVID-19 vaccine | Montero-Menárguez et al |
| https://pubmed.ncbi.nlm.nih.gov/34841025/ | Widespread cutaneous reaction to the Johnson & Johnson Ad26.COV2.S vaccine | Sowell et al |
| https://pubmed.ncbi.nlm.nih.gov/33997209/ | Widespread annular eruption after Ad26.COV2.S COVID-19 vaccine | Song & Wong |
| https://pubmed.ncbi.nlm.nih.gov/35770484/ | New-onset systemic lupus erythematosus after ChAdOX1 nCoV-19 and alopecia areata after BNT162b2 vaccination against SARS-CoV-2 | Gamonal et al |
| https://pubmed.ncbi.nlm.nih.gov/35789521/ | Intractable alopecia areata following the second dose of COVID-19 vaccination: Report of two cases | Chen CH et al |
| https://pubmed.ncbi.nlm.nih.gov/34559937/’ | Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca): a potential triggering factor? | Essam et al |
| https://pubmed.ncbi.nlm.nih.gov/35223675/ | Alopecia areata after COVID-19 vaccination | Gallo et al |
| https://pubmed.ncbi.nlm.nih.gov/35107173/ | Alopecia areata following COVID-19 vaccination: vaccine-induced autoimmunity? | Lee MM et al |
| https://pubmed.ncbi.nlm.nih.gov/35571458/ | Letter in Reply: Alopecia areata after SARS-CoV-2 vaccination | Lo et al |
| https://pubmed.ncbi.nlm.nih.gov/34741583/ | Recurrence of alopecia areata after covid-19 vaccination: A report of three cases in Italy – PubMed | Rossi et al |
| https://pubmed.ncbi.nlm.nih.gov/34931171/ | Alopecia areata after SARS-CoV-2 vaccination | Scollan et al |
| https://pubmed.ncbi.nlm.nih.gov/35716105/ | Cutaneous manifestations following COVID-19 vaccination: A report of 25 cases | Shakoei et al |
| https://pubmed.ncbi.nlm.nih.gov/35642187/ | Alopecia universalis with unusual histopathologic features after vaccination with ChAdOx1 nCoV-19 (AZD1222) | Ho JD et al |
| https://pubmed.ncbi.nlm.nih.gov/35379574/ | Alopecia areata following ChAdOx1 nCoV-19 vaccination (Oxford/AstraZeneca) | Su HA et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/35070594/ | Alopecia Areata Treated with Advanced Platelet-rich Fibrin Using Micronization | Vazquez et al |
| https://pubmed.ncbi.nlm.nih.gov/35771095/ | Influence of Covid-19 vaccination on immune-mediated skin diseases | Alelq et al |
| https://pubmed.ncbi.nlm.nih.gov/35754159/ | Cutaneous lupus erythematosus-like reaction arising after COVID-19 vaccination | Rose C et al |
| https://pubmed.ncbi.nlm.nih.gov/35624558/ | Subacute cutaneous lupus erythematosus following ChAdOx1 nCoV-19 vaccination | Wang WY et al |
| https://pubmed.ncbi.nlm.nih.gov/35529074/ | A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccine | Wada et al |
| https://pubmed.ncbi.nlm.nih.gov/35465138/ | Pityriasis rubra pilaris potentially triggered by messenger RNA-1273 COVID vaccine | Ajebo et al |
| https://pubmed.ncbi.nlm.nih.gov/35278239/ | Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin | Criado et al |
| https://pubmed.ncbi.nlm.nih.gov/35968197/ | Leukocytoclastic Vasculitis following the First Dose of the Elasomeran COVID-19 Vaccination | Casale et al |
| https://pubmed.ncbi.nlm.nih.gov/36000937/ | Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing | Siripipattanamongkol et al |
| https://pubmed.ncbi.nlm.nih.gov/35986626/ | Stevens-Johnson syndrome after ChAdOx1 nCoV-19 vaccine | da Cruz Gouveia et al |
| https://pubmed.ncbi.nlm.nih.gov/35966160/ | Stevens-Johnson syndrome related with Comirnaty® coronavirus disease 2019 vaccine | Marcelino et al |
| https://pubmed.ncbi.nlm.nih.gov/34466640/ | Acute generalized exanthematous pustulosis induced by Moderna COVID-19 messenger RNA vaccine | Agaronov et al |
| https://pubmed.ncbi.nlm.nih.gov/34485656/ | Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine | Drohan et al |
| https://pubmed.ncbi.nlm.nih.gov/34485657/ | Cutaneous hypersensitivity reaction with acute hepatitis following COVID-19 vaccine | Wong CY & Rios |
| https://pubmed.ncbi.nlm.nih.gov/34495381/ | Vasculitis and bursitis on [ 18 F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc? | Schierz et al |
| https://pubmed.ncbi.nlm.nih.gov/34611627/ | Cutaneous vasculitis following COVID-19 vaccination | Cavalli et al |
| https://pubmed.ncbi.nlm.nih.gov/34746453/ | «COVID arm» detected by MR neurography | Komiya et al |
| https://pubmed.ncbi.nlm.nih.gov/34816549/ | Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series | Martora et al |
| https://pubmed.ncbi.nlm.nih.gov/34821411/ | A case of erythroderma with elevated serum immunoglobulin E and thymus and activation-regulated chemokine levels following coronavirus disease 2019 vaccination | Iwasawa et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34961975/ | Lichenoid drug eruption after coronavirus disease 2019 vaccination | Baba et al |
| https://pubmed.ncbi.nlm.nih.gov/35092306/ | Bullous neutrophilic dermatosis with severe acral oedema post-COVID-19 mRNA vaccination | Goubar et al |
| https://pubmed.ncbi.nlm.nih.gov/35184341/ | Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccination | Mäkilä et al |
| https://pubmed.ncbi.nlm.nih.gov/35653233/ | Sweet-like syndrome and multiple COVID arm syndrome following COVID-19 vaccines: ‘specific’ patterns in a series of 192 patients | Darrigade et al |
| https://pubmed.ncbi.nlm.nih.gov/35698860/ | Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2 | Ramot et al |
| https://pubmed.ncbi.nlm.nih.gov/34337124/ | Cutaneous small vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination | Berry CT et al |
| https://pubmed.ncbi.nlm.nih.gov/34337193/ | Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine | Salem F et al |
| https://pubmed.ncbi.nlm.nih.gov/34363637/ | Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature | Annabi et al |
| https://pubmed.ncbi.nlm.nih.gov/34366434/ | [Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine] | González-Romero et al |
| https://pubmed.ncbi.nlm.nih.gov/34374333/ | Pityriasis Rosea as a Possible Complication of Vaccination Against COVID-19 | Dormann et al |
| https://pubmed.ncbi.nlm.nih.gov/34414254/ | Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathology | Chopra et al |
| https://pubmed.ncbi.nlm.nih.gov/34487574/ | Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis | Wu RW & Lin TK |
| https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12278 | Persistent varicella zoster virus infection following mRNA COVID-19 vaccination was associated with the presence of encoded spike protein in the lesion | Yamamoto M |
| https://pubmed.ncbi.nlm.nih.gov/36072649/ | Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 Vaccination | Aryanian et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/36068793/ | Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapy | El-Behaedi et al |
| https://pubmed.ncbi.nlm.nih.gov/36062201/ | A case of recurrent fixed drug eruption following two different coronavirus disease 2019 vaccination verified through intradermal and patch tests | Seol EJ et al |
| https://pubmed.ncbi.nlm.nih.gov/35604041/ | Nail psoriasis: a rare mRNA COVID-19 vaccine reaction | Lamberti A et al |
| https://pubmed.ncbi.nlm.nih.gov/36098769/ | New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review | Sagy et al |
| https://pubmed.ncbi.nlm.nih.gov/36035769/ | Sever erythema multiforme post-COVID-19 moderna vaccine: Case report and literature review | Fadul et al |
| https://pubmed.ncbi.nlm.nih.gov/36035747/ | COVID-19 Vaccination Related Exacerbations of Hair Loss in Patients with Moderate to Severe Alopecia Areata on Systemic Therapy | Babadjouni et al |
| https://pubmed.ncbi.nlm.nih.gov/36004038/ | Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl | Rubaian et al |
| https://pubmed.ncbi.nlm.nih.gov/35991953/ | Sweet syndrome following Moderna COVID-19 vaccine: A case report | Pelchat et al |
| https://pubmed.ncbi.nlm.nih.gov/35975094/ | Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review | Abdalla & Ebrahim |
| https://pubmed.ncbi.nlm.nih.gov/35966159/ | Delayed urticaria after BNT162b2 booster vaccination at previous intradermal test site with severe acute respiratory syndrome-coronavirus-2 spike protein | Triwatcharikorn et al |
| https://pubmed.ncbi.nlm.nih.gov/35936173/ | COVID-19 Vaccine Booster-Induced Dermatographism | Amjad et al |
| https://pubmed.ncbi.nlm.nih.gov/35922892/ | Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine | Nahm et al |
| https://pubmed.ncbi.nlm.nih.gov/35916826/ | Eyelid edema following the first Pfizer-BioNTech COVID-19 vaccination: is it a coincidence? | Baysal & Gobeka |
| https://pubmed.ncbi.nlm.nih.gov/35911257/ | Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination | Shansal |
| https://pubmed.ncbi.nlm.nih.gov/35892478/ | Pseudo-Pemphigoid Gestationis Eruption Following SARS-CoV-2 Vaccination with mRNA Vaccine | de Lorenzi et al |
| https://pubmed.ncbi.nlm.nih.gov/35880298/ | Under-awareness and over-diagnosis of COVID-19 vaccine ‘allergy’ | Chiang V et al |
| https://pubmed.ncbi.nlm.nih.gov/35875513/ | Pityriasis lichenoides chronica induced by COVID-19 messenger RNA vaccination | Muqrin et al |
| https://pubmed.ncbi.nlm.nih.gov/35855232/ | Psoriasis Flares in Patients With COVID-19 Infection or Vaccination: A Case Series | Shah & Busquets |
| https://pubmed.ncbi.nlm.nih.gov/35851250/ | Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases | Raccampo et al |
| https://pubmed.ncbi.nlm.nih.gov/35850789/ | Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccine | Ahmer et al |
| https://pubmed.ncbi.nlm.nih.gov/35850104/ | ANCA-Associated Vasculitis following the First Dose of Pfizer-BioNTech COVID-19 Vaccine | Hasbani & Uthman |
| https://pubmed.ncbi.nlm.nih.gov/35845348/ | New-onset pemphigus vegetans and pemphigus foliaceus after SARS-CoV-2 vaccination: A report of 2 cases | Gui H et al |
| https://pubmed.ncbi.nlm.nih.gov/35835178/ | Gianotti-Crosti Syndrome of Atypical Location in an Adult Following SARS-CoV-2 Vaccination | Pestana et al |
| https://pubmed.ncbi.nlm.nih.gov/35832214/ | ANCA-associated vasculitis following Johnson and Johnson COVID-19 vaccine | Yadav et al |
| https://pubmed.ncbi.nlm.nih.gov/35812079/ | Acute vulvar ulcers and the COVID-19 booster vaccine | Salusti-Simpson et al |
| https://pubmed.ncbi.nlm.nih.gov/35811413/ | Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review | Antoñanzas et al |
| https://pubmed.ncbi.nlm.nih.gov/35789676/ | Blaschkolinear acquired inflammatory skin eruption (blaschkitis) following COVID-19 vaccination | Rovira-López & Pujol |
| https://pubmed.ncbi.nlm.nih.gov/35756074/ | Vitiligo of the arm after COVID-19 vaccination | Singh R et al |
| https://pubmed.ncbi.nlm.nih.gov/36185929/ | Relapse of Palmoplantar Pustulosis Following COVID-19 Vaccination | Katsuie et al |
| https://pubmed.ncbi.nlm.nih.gov/36183151/ | Lichen planus pigmentosus post COVID-19-vaccination | Chaima et al |
| https://pubmed.ncbi.nlm.nih.gov/36182117/ | Livedo reticularis after COVID-19 vaccination | Horino et al |
| https://pubmed.ncbi.nlm.nih.gov/36164291/ | New-Onset Lichen Planus Induced by the Pfizer COVID-19 Vaccine | Alghamdi et al |
| https://pubmed.ncbi.nlm.nih.gov/36136900/ | Livedoid skin reaction to 2nd dose of mRNA Covid-19 vaccine | Girolami et al |
| https://pubmed.ncbi.nlm.nih.gov/36219526/ | Atypical presentation of Sweet syndrome with nodular erythema and oral ulcerations provoked by Ad26.COV2.S SARS-CoV-2 vaccination and review of literature | Bechtold & Owczarczyk-Saczonek |
| https://pubmed.ncbi.nlm.nih.gov/36125778/ | Asymmetric Periflexural Exanthem in an Adult Patient After Pfizer-BioNTech COVID-19 Vaccine | Thabouti et al |
| https://pubmed.ncbi.nlm.nih.gov/36259862/’ | A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination | Daines et al |
| https://pubmed.ncbi.nlm.nih.gov/36340858/ | Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccine | Bakr et al |
| https://pubmed.ncbi.nlm.nih.gov/36340561/ | A Patient Develops Bullous Rash After Receiving the Second Dose of COVID-19 Vaccine | Nida SS et al |
| https://pubmed.ncbi.nlm.nih.gov/36314709/ | A Histologic Timeline of a Delayed Hypersensitivity Reaction after the COVID-19 Pfizer Booster | Strong HA et al |
| https://pubmed.ncbi.nlm.nih.gov/36304618/ | Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech) | Batta et al |
| https://pubmed.ncbi.nlm.nih.gov/36302245/ | Severe cutaneous reaction to the messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) vaccine | Sapsford & Wood |
| https://pubmed.ncbi.nlm.nih.gov/36298511/ | Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo | Macca et al |
| https://pubmed.ncbi.nlm.nih.gov/35595719/ | New onset and exacerbation of oral lichenoid mucositis following SARS-CoV-2 infection or vaccination | Alabdulaaly et al |
| https://pubmed.ncbi.nlm.nih.gov/35560571/ | Flare-up of generalized pustular psoriasis following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: Two cases without mutations of IL36RN and CARD14 genes | Tachibana et al |
| https://pubmed.ncbi.nlm.nih.gov/34897817/ | Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient | Knechtl et al |
| https://pubmed.ncbi.nlm.nih.gov/36592149/ | Tozinameran (Pfizer-BioNTech COVID-19 vaccine)-induced AGEP-DRESS syndrome | Tay WC et al |
| https://pubmed.ncbi.nlm.nih.gov/36592047/ | mRNA-1273 COVID-19 vaccine-induced Steven-Johnson syndrome | Lo HK et al |
| https://pubmed.ncbi.nlm.nih.gov/36591352/ | Rash, Abdominal Pain, Proteinuria, and AKI after COVID-19 Vaccination | Lazoff et al |
| https://pubmed.ncbi.nlm.nih.gov/36590078/ | An asymmetric morbilliform eruption in an adult male | Yelich et al |
| https://pubmed.ncbi.nlm.nih.gov/36562098/ | A rare presentation of rapidly progressing myopathy in an adolescent | Pepys et al |
| https://pubmed.ncbi.nlm.nih.gov/36540524/ | A Case Report of Exfoliative Bullous Rash Following AstraZeneca Vaccine | Saleem & Goh |
| https://pubmed.ncbi.nlm.nih.gov/36531266/ | Lipschütz ulceration in a 12-year-old girl following second dose of Comirnaty (Pfizer) COVID-19 vaccine | Frederiks et al |
| https://pubmed.ncbi.nlm.nih.gov/36514459/ | Generalized fixed drug eruption following Pfizer-BioNtech COVID-19 vaccination | Kabir S et al |
| https://pubmed.ncbi.nlm.nih.gov/36504544/ | Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report | Ahmed F et al |
| https://pubmed.ncbi.nlm.nih.gov/36503530/ | Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine | Di Bona et al |
| https://pubmed.ncbi.nlm.nih.gov/36466142/ | Localized eczematous rash affecting left and right regions of breast and shoulder after Ad26.COV2.S vaccine against COVID-19 in a 30-year-old woman with comorbidities | Anasiewicz et al |
| https://pubmed.ncbi.nlm.nih.gov/36451671/ | Livedo reticularis following administration of ChAdOx1 nCoV-19 vaccine (AZD1222): a report of two cases | Kim JH et al |
| https://pubmed.ncbi.nlm.nih.gov/36451284/ | Erythema nodosum after COVID-19 vaccine: Report of two pediatric cases | Gonzalez-Canete et al |
| https://pubmed.ncbi.nlm.nih.gov/36448713/ | Systemic lupus erythematosus with acrocyanosis after AstraZeneca COVID-19 vaccination | Wang HJ et al |
| https://pubmed.ncbi.nlm.nih.gov/36426538/ | Pyoderma Gangrenosum Triggered by COVID-19 Vaccination in a Patient with Ulcerative Colitis: A Case Report | Kim YC et al |
| https://pubmed.ncbi.nlm.nih.gov/36423067/ | A Case of Purpura Annularis Telangiectodes of Majocchi after Anti-SARS-CoV-2 Pfizer-BioNTech Vaccine: Is There an Association? | Ambrogio et al |
| https://pubmed.ncbi.nlm.nih.gov/36406337/ | Resolution of recalcitrant verruca following Moderna COVID-19 vaccination in a person with HIV | Bressler et al |
| https://pubmed.ncbi.nlm.nih.gov/36647894/ | An impressive case of alopecia universalis after COVID-19 vaccination: a coincidental finding or a consequence? | Peterle et al |
| https://pubmed.ncbi.nlm.nih.gov/36638370/ | Psoriasiform Dermatitis Associated With the Moderna COVID-19 Messenger RNA Vaccine | Daneshbod et al |
| https://pubmed.ncbi.nlm.nih.gov/36626570/ | Pityriasis Rubra Pilaris After Moderna COVID-19 Vaccination: A Case Report and Literature Review | Liu Ya et al |
| https://pubmed.ncbi.nlm.nih.gov/36624889/ | A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 Vaccination | Gomez YS et al |
| https://pubmed.ncbi.nlm.nih.gov/36683345/ | Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on «cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine» by Luo et al | Martora et al |
| https://pubmed.ncbi.nlm.nih.gov/35170477/ | Acantholytic Dyskeratosis Post-COVID Vaccination | Yang K et al |
| https://pubmed.ncbi.nlm.nih.gov/36514624/ | COVID-19 Vaccine: A Common Suspect but Rare Culprit in Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome | Hanna & Yang |
| https://pubmed.ncbi.nlm.nih.gov/36057958/ | Erythema multiforme following vaccination for SARS-CoV-2: Report of a case and review of the literature – Secondary Publication | Kobyashi Y et al |
| https://pubmed.ncbi.nlm.nih.gov/34821413/ | Case of atypical erythema multiforme following coronavirus disease 2019 vaccination | Iwasawa et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34865149/ | Erythema multiforme after SARS-CoV-2 messenger RNA vaccination | *NO AUTHOR* |
| https://pubmed.ncbi.nlm.nih.gov/34547145/ | Nevocentric erythema multiforme after SARS-COV-2 vaccine | Scharf C et al |
| https://pubmed.ncbi.nlm.nih.gov/34667612/ | Erythema Multiforme Major following SARS-CoV-2 vaccine | Saibene et al |
| https://pubmed.ncbi.nlm.nih.gov/35492355/ | Case Report: Idiopathic Subcutaneous Thrombotic Vasculopathy | Godbe et al |
| https://pubmed.ncbi.nlm.nih.gov/35441091/ | Eyelid erythema after coronavirus vaccination | Bárcena-Dahl et al |
| https://pubmed.ncbi.nlm.nih.gov/35652448/ | Urticarial vasculitis after COVID-19 vaccination: A case report and literature review | Ono et al |
| https://pubmed.ncbi.nlm.nih.gov/36511288/ | Exacerbation of Chronic Cutaneous Lupus Erythematosus Triggered by Vaccine Against COVID-19 | Souza EN et al |
| https://pubmed.ncbi.nlm.nih.gov/36246778/ | New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literature | Khanna et al |
| https://pubmed.ncbi.nlm.nih.gov/34529877/ | Cutaneous small-vessel vasculitis following COVID-19 vaccine | Kar BR et al |
| https://pubmed.ncbi.nlm.nih.gov/35690533/ | A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 Vaccination | Ball-Burack & Kosowsky |
| https://pubmed.ncbi.nlm.nih.gov/36146490/ | Delayed Skin Reactions to COVID-19 mRNA-1273 Vaccine: Case Report and Literature Review | Wang RL et al |
| https://pubmed.ncbi.nlm.nih.gov/35818815/ | Symptomatic hyponatremia after ChAdOx1 nCoV-19 coronavirus disease-19 vaccination | Chienwichai et al |
